Suven Life Sciences Ltd
Suven Life Scie. | 530239
SUVEN - Share Price Chart
Stock Performance
Ratios
About Company
- Suven Life Sciences Limited was initially established as 'Suven Pharmaceuticals Limited' in March, 1989 and changed to the present name in September 2003
- The Company is a clinical-stage biopharma company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders
- Company focus on the discovery and clinical development of innovative medicines to address the unmet medical needs in central nervous system (CNS) disorders
- Promoted by Venkateswarlu Jasti, Company began the business in 1989 as specialty chemicals provider
- In March 1995, the Company came out with a public issue of 9
- 8 lac equity shares at a premium of Rs 40 aggregating Rs 4
- 9 cr to part-finance the company's project for the manufacture of bulk drugs and drug intermediates and meet long-term working capital requirements totalling to Rs 6
- During 1999-2000, the company acquired a small pilot plant in Jeedimetla Industrial Estate, Hyderabad
- During 2000-01, the company has registered a most remarkable record
- The total sales of the company during 2000-01 have registered a growth of 71% over the previous year
Ethics: Suven Life Sciences Ltd is flagged for
Adequate
The company demonstrates adequate ESG practices with room for improvement.
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Gainers
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Suven Life Sciences Ltd?
The current share price of Suven Life Sciences Ltd (Suven Life Scie.) is ₹381.60. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Suven Life Sciences Ltd?
The Price-to-Earnings (P/E) ratio of Suven Life Sciences Ltd is 381.60. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Suven Life Sciences Ltd?
Suven Life Sciences Ltd has a 52-week high of ₹403.35 and a 52-week low of ₹124.11. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Suven Life Sciences Ltd?
Suven Life Sciences Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Suven Life Sciences Ltd?
The Earnings Per Share (EPS) of Suven Life Sciences Ltd is ₹-12.47. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Suven Life Sciences Ltd?
Suven Life Sciences Ltd has a Return on Equity (ROE) of -5.59%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
